Luteolin, quercetin and ursolic acid are potent inhibitors of proliferation and inducers of apoptosis in both KRAS and BRAF mutated human colorectal cancer cells
- 1 August 2009
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 281 (2) , 162-170
- https://doi.org/10.1016/j.canlet.2009.02.041
Abstract
No abstract availableKeywords
Funding Information
- Fundação para a Ciência e a Tecnologia (POCI/AGR/62040/2004, SFRH/BD/27524/2006, SFRH/BPD/26316/2006)
This publication has 51 references indexed in Scilit:
- Raf and MEK Protein Kinases Are Direct Molecular Targets for the Chemopreventive Effect of Quercetin, a Major Flavonol in Red WineCancer Research, 2008
- Biomarkers for diet and cancer prevention research: potentials and challengesActa Pharmacologica Sinica, 2007
- Differential regulation and properties of MAPKsOncogene, 2007
- Phenolic compounds protect HepG2 cells from oxidative damage: Relevance of glutathione levelsLife Sciences, 2006
- Inhibitory effect of luteolin on hepatocyte growth factor/scatter factor-induced HepG2 cell invasion involving both MAPK/ERKs and PI3K–Akt pathwaysChemico-Biological Interactions, 2006
- Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistanceAdvances in Enzyme Regulation, 2006
- BRAF mutation predicts sensitivity to MEK inhibitionNature, 2005
- The prevalence of PIK3CA mutations in gastric and colon cancerEuropean Journal Of Cancer, 2005
- Cancer chemoprevention with dietary phytochemicalsNature Reviews Cancer, 2003
- The inhibition of phosphatidylinositol 3-kinase by quercetin and analogsBiochemical and Biophysical Research Communications, 1992